Research News and Research

RSS

Santaris Pharma advances SPC4955 into Phase 1 trial for high cholesterol treatment

Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the research and development of mRNA and microRNA targeted therapies, today announced that it has advanced a second drug from its cardiometabolic program, SPC4955 into Phase 1 clinical trials, for the treatment of high cholesterol.

11 May 2011

ImmunID, Centre Léon Bérard and Cytheris commence CYT107-XELODA Phase IIa trial in metastatic breast cancer

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard, the major cancer research and treatment center for the Rhône-Alpes region of France, and ImmunID Technologies SAS, a diagnostic company specialized in innovative immunomonitoring tests and services, today announced initiation of a Phase IIa clinical trial that will evaluate multiple combinations of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, and a chemotherapeutic agent, XELODA, in the treatment of metastatic breast cancer.

11 May 2011

First Edition: May 11, 2011

Reporting for Kaiser Health News, Hilary Abramson writes: "Now comes the hard part. California, which has had a long, sometimes-tortured history of trying to overhaul its health care markets, beat every other state last year when it passed a law creating a health insurance exchange - an online marketplace where millions of uninsured residents will be able to get insurance".

11 May 2011

Two new policy briefs on California health reform law

According to two new policy briefs from the UCLA Center for Health Policy Research, the majority of state residents likely to be eligible for federally mandated health insurance coverage initiatives in California in 2014 are also those who may be least likely to excessively use costly health services: men, singles and those of working age.

11 May 2011

Pacira Pharmaceuticals reports net loss of $9.8 million for first quarter 2011

Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced financial results for the first quarter ended March 31, 2011, provided an update on the execution of its pre-commercial and launch strategies for EXPAREL, and reiterated 2011 financial guidance.

11 May 2011

Challenges to health law take center stage with appellate court action

President Obama's health care law faces a series of challenges in three appeals courts starting Tuesday as Republican lawyers from 27 states will urge the courts to strike down the law as unconstitutional. In a sign of the high stakes and the partisan divide, one case will feature a rare courtroom clash between the Obama administration's top appellate lawyer and his counterpart from the George W. Bush administration.

11 May 2011

Amylin, JDRF collaborate to investigate combination therapy for type 1 diabetes treatment

The Juvenile Diabetes Research Foundation and Amylin Pharmaceuticals, Inc. announced today that they have entered into a research collaboration agreement to provide financial support for a series of clinical studies to investigate the feasibility of mixing pramlintide, an analog of the human hormone amylin, with insulin to treat type 1 diabetes.

11 May 2011

Heart docs dismiss bias claims stemming from industry support of meeting

Doctors said the heart society meeting was an important opportunity to learn about new research in their field and see new products on the market. Unlike in many other areas of medicine, they said, electrophysiologists work hand-in-hand with device company representatives to program implantable defibrillators and diagnose problems.

11 May 2011

Engineers develop novel hybrid HMI for hands-free control of electric powered wheelchairs

For people with severe physical disabilities, such as spinal cord injury, quadriplegia and hemiplegia or amputation, current technology for controlling a wheelchair or mobility scooter is wholly inadequate.

11 May 2011

ICON partners with BCRI for clinical research

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced a strategic alliance with Boston Clinical Research Institute, an Academic Research Organisation based in Boston, Massachusetts.

11 May 2011

Study: Many patients screened for colon cancer more often than recommended

Many patients are getting screened for colorectal cancer more often than guidelines recommend, hints a new study.

11 May 2011

Common tiny tropical fish plays a key role in new model for Cushing disease

A common, tiny tropical fish plays a key role in a new model for Cushing disease, giving researchers a powerful tool to conduct extensive searches for effective treatments for this serious hormonal disorder, testing up to 300 drugs weekly.

11 May 2011

Medicare, entitlement reform continue to trigger political rifts

The AP reports that, as unlikely as it may seem, the Obama administration and congressional Republicans may share some common ideas regarding Medicare costs. Still, the issue of how to address the programs — and the related proposals — still are causing rifts within the GOP.

11 May 2011

NAA calls for immediate Congressional hearings and scientific investigation into autism-vaccine link

Despite numerous studies cited repeatedly by federal officials as proof that vaccines do not cause autism, a new study released today in the Pace Environmental Law Review revealed that over the last two decades, the National Vaccine Injury Compensation Program has been quietly compensating dozens of vaccine injury cases involving a child with autism.

11 May 2011

Georgia to review Medicaid changes; Calif. judge rules against freeze on payments for disability services

In any other year, a historic overhaul of the Medicaid system would have overshadowed every health issue in the Legislature. But when lawmakers went home early Saturday morning, Medicaid might not have even been the noisiest health-related debate of the 2011 legislative session. Lawmakers passed a nearly $70 billion budget that included deep cuts to hospitals, nursing homes and dozens of other health programs.

11 May 2011

Majority of urban NYC women with hepatitis B do not receive education, subsequent care

According to new research at Columbia Presbyterian Medical Center, high rates of chronic hepatitis B infection are found in pregnant minority and immigrant women in the New York City area, and most of them do not receive education, appropriate follow-up testing or referral, which is considered the standard of care for all persons newly identified as HBV carriers.

11 May 2011

Inovio first quarter total revenue increases to $3.1 million for 2011

Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2011.

11 May 2011

USA Today: Uninsured hospitalizations result in a hefty unpaid tab

Uninsured Americans — including those with incomes well above the poverty line — leave hospitals with unpaid tabs of up to $49 billion a year, according to a government study released today. On average, uninsured families pay only about 12 percent of their hospital bills in full.

11 May 2011

Research provides insight into brain reorganization following sensory loss

The part of the brain that uses hearing to determine sound location is reorganized in deaf animals to locate visual targets, according to a new study by a team of researchers from Virginia Commonwealth University and the University of Western Ontario in Canada.

11 May 2011

Study finds strong link between live birth rates and number of eggs retrieved in one IVF cycle

An analysis of over 400,000 IVF cycles in the UK has shown that doctors should aim to retrieve around 15 eggs from a woman's ovaries in a single cycle in order to have the best chance of achieving a live birth after assisted reproduction technology.

11 May 2011

Research News and Research

Santaris Pharma advances SPC4955 into Phase 1 trial for high cholesterol treatment

ImmunID, Centre Léon Bérard and Cytheris commence CYT107-XELODA Phase IIa trial in metastatic breast cancer

First Edition: May 11, 2011

Two new policy briefs on California health reform law

Pacira Pharmaceuticals reports net loss of $9.8 million for first quarter 2011

Challenges to health law take center stage with appellate court action

Amylin, JDRF collaborate to investigate combination therapy for type 1 diabetes treatment

Heart docs dismiss bias claims stemming from industry support of meeting

Engineers develop novel hybrid HMI for hands-free control of electric powered wheelchairs

ICON partners with BCRI for clinical research

Study: Many patients screened for colon cancer more often than recommended

Common tiny tropical fish plays a key role in new model for Cushing disease

Medicare, entitlement reform continue to trigger political rifts

NAA calls for immediate Congressional hearings and scientific investigation into autism-vaccine link

Georgia to review Medicaid changes; Calif. judge rules against freeze on payments for disability services

Majority of urban NYC women with hepatitis B do not receive education, subsequent care

Inovio first quarter total revenue increases to $3.1 million for 2011

USA Today: Uninsured hospitalizations result in a hefty unpaid tab

Research provides insight into brain reorganization following sensory loss

Study finds strong link between live birth rates and number of eggs retrieved in one IVF cycle

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Latest eBooks

Industry Focus eBook - Life Science Microscopy (2nd Edition)

Event guide: 2nd World RNA-Based Therapeutics & Vaccines Summit Korea

New horizons in drug discovery: High-throughput & target-to-therapy advances

A practical guide to lipid nanoparticle formulation and resizing

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance